Sign in
Stories
Dermal Fillers and Blindness
Share
Collagen Market Growth Driven by Surgeri...
Disposable Face Masks and Facial Tissues...
Growing Healthcare Markets in South Afri...
APR Corp. Reports Q3 Growth
Anti-Aging Skin-Care Controversy
Anti-Pollution Ingredients Market Growth
Overview
API
A woman in Singapore lost her eyesight after receiving dermal fillers, prompting an investigation by the Health Sciences Authority (HSA). Dermal fillers carry a known risk of causing blood vessel blockages that can result in blindness. The case involved a non-HA filler with poly-D-L-lactic acid (PDLLA) as its main ingredient, which cannot be reversed. The global hyaluronic acid market is projected to reach a value of USD 14.84 billion by 2030, driven by the increasing interest in injectable hyaluronic acid and the growing demand for minimally invasive cosmetic procedures.
Ask a question
How can the high cost of hyaluronic acid-based offerings be addressed?
What are the potential long-term complications associated with the use of dermal fillers?
What measures can be taken to reduce the risk of blindness from dermal fillers?
Article Frequency
0.2
0.4
0.6
0.8
1.0
May 2023
Jun 2023
Jul 2023
Aug 2023
Coverage